<?xml version="1.0" encoding="UTF-8"?>
<p>The scale-up of ART averted 5.4 million deaths in low- and middle-income countries worldwide between 1995 and 2012. Given the limitations of ART and recent advances in our understanding of HIV persistence with current treatment regimens, there is a growing recognition, although a remote dream, that a functional cure for HIV infection is both needed and feasible
 <xref rid="ref12" ref-type="bibr">12</xref>. Several clinical trials are ongoing with various drugs and broadly neutralizing monoclonal antibodies administered during the early acute HIV infection phase to study whether HIV viral load would remain undetectable after treatment interruption.
</p>
